New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Supernus Pharmaceuticals, Inc.
SUPN
Shape
US Flag

NASDAQ

EPS improving

EPS improving

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 04 Nov 2024

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 04 Nov 2024

34.27USD
Shape0.47 ( 1.39%)
Market Open
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated October 25, 2024
1W 1.78 % 1M 11.37 % 3M 11.45 % 1Y 50.84 %

Key Metrics

Shape
  • Market Cap

    1.89B


  • Shares Outstanding

    55.11M


  • Share in Float

    52.76M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    34.27


  • Average Volume

    391764


  • Beta

    0.88


  • Range

    21.99-35.44


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.supernus.com


  • Sector

    Healthcare


Fundamentals

Shape

97.91x

P/E Ratio

2.96x

P/S Ratio

1.94x

P/B Ratio

0.0

Debt/Equity

0.8%

Net Margin

$0.1

EPS

How SUPN compares to sector?

P/E Ratio

Relative Strength

Shape

SUPN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$620M

Shape268%

2025-Revenue

$0.87

Shape-342%

2025-EPS

$177M

Shape356%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

downgrade

Previous: Overweight

2024-09-10

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-92%

0.03
vs 0.4

Q4.22

arrow
arrow

+860%

0.43
vs 0.04

Q1.23

arrow
arrow

-33%

0.29
vs 0.43

Q2.23

arrow
arrow

N/A

-0.02
vs 0.14

Q3.23

arrow
arrow

N/A

-0.29
vs 0.03

Q4.23

arrow
arrow

-95%

0.02
vs 0.43

Q1.24

arrow
arrow

-10%

0.26
vs 0.29

Q2.24

arrow
arrow

+1900%

0.36
vs -0.02

Q3.24

arrow
arrow

+253%

0.44
vs -0.29

Q4.24

arrow
arrow

+1533%

0.33
vs 0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+19%

177.4M  vs 148.5M

Q4.22

arrow
arrow

+5%

167.3M  vs 159.1M

Q1.23

arrow
arrow

+1%

153.8M  vs 152.5M

Q2.23

arrow
arrow

-20%

135.6M  vs 170.1M

Q3.23

arrow
arrow

-13%

153.9M  vs 177.4M

Q4.23

arrow
arrow

-2%

164.3M  vs 167.3M

Q1.24

arrow
arrow

-7%

143.6M  vs 153.8M

Q2.24

arrow
arrow

+24%

168.3M  vs 135.6M

Q3.24

arrow
arrow

+2%

157.3M  vs 153.9M

Q4.24

arrow
arrow

-9%

150.2M  vs 164.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+0%

0
vs 0.01

Q4.22

arrow
arrow

+3%

0.03
vs 0

Q1.23

arrow
arrow

+2%

0.02
vs 0.03

Q2.23

arrow
arrow

0%

-0.00
vs 0.02

Q3.23

arrow
arrow

-2%

-0.02
vs -0.00

Q4.23

arrow
arrow

+0%

0
vs -0.02

Q1.24

arrow
arrow

+0%

0
vs 0

Q2.24

arrow
arrow

+2%

0.02
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

241

241
vs 223

8%

Q4.22

arrow
arrow

262

262
vs 241

9%

Q1.23

arrow
arrow

262

262
vs 262

NA

Q2.23

arrow
arrow

254

254
vs 262

-3%

Q3.23

arrow
arrow

240

240
vs 254

-6%

Q4.23

arrow
arrow

248

248
vs 240

3%

Q1.24

arrow
arrow

254

254
vs 248

2%

Q2.24

arrow
arrow

245

245
vs 254

-4%

Earnings Growth

Latest News